04 /27 | MIL Group Webinar – Training Opportunities in Clinical and Basic Research in LATAM

A new SOLACI – CACI joint event is coming, Women as One, with the support of Boston Scientific

In this new educational endeavor, we will focus on training opportunities in clinical and basic research in LATAM for women interventionists to develop their professional career in this area. 

In this context, different international leaders in the field will deliver appealing presentations intended to provide the audience with different practical tools

Date: April 27, 2022 at 06.30 PM (Argentina / Brasil; UTC-3).

This event is open and free of charge. Look at our program below to find out all about these activities and sign up!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Highlights of the SOLACI@EuroPCR 2025 Session

Relive the best moments of the joint session organized by SOLACI during the EuroPCR 2025 Congress on “Clinical and technical factors for decision-making in...

SOLACI Symposium at the EuroPCR 2025 Congress

The Latin American Society of Interventional Cardiology (SOLACI) makes a strong appearance once again at one of the most important congresses in the field...

See the best images from the Uruguay 2025 Sessions

Enjoy the best moments of the Uruguay 2025 Conference, held at the Radisson Hotel in Montevideo (Uruguay) on May 7, 8, and 9, 2025. <!--...

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as the standard treatment in patients with acute...

iVAC2L: New Contribution to Ventricular Assist Devices in High Risk PCIs

The use of mechanical circulatory support (MCS) is on the rise, or increasingly necessary, seeing as high risk percutaneous coronary interventions (HR-PCIs) with severe...